The Claim
Long-term administration of selenium nanoparticles (50 μg Se/kg/day for 24 weeks) in apolipoprotein E-deficient mice on a high-fat diet is associated with worsened hyperlipidemia through hepatic lipid metabolic disruption.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In apolipoprotein E-deficient mice fed a high-fat diet, daily selenium nanoparticle supplementation at 50 μg Se/kg for 24 weeks leads to increased blood lipid levels due to altered liver lipid metabolism.
See the scientific wording
Long-term administration of selenium nanoparticles (50 μg Se/kg/day for 24 weeks) in apolipoprotein E-deficient mice on a high-fat diet is associated with worsened hyperlipidemia through hepatic lipid metabolic disruption.
Selenium nanoparticles build up in the liver, shut down key antioxidant enzymes, and cause a surge of damaging molecules that interfere with how the liver handles fats. This causes the liver to make more fats and stop clearing them from the blood, leading to high levels of cholesterol and triglycerides in the bloodstream.
What the research says
1 studyIn mice with high cholesterol, giving them selenium nanoparticles for six months made their blood fat levels worse and hurt their liver’s ability to process fats, exactly as the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.